Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24044014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elena Ricciardi und 11 weiteren Autor:innen. Beteiligte Einrichtung: UOC Oncological Translational Research, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Melanoma, Neoplasms, Second Primary, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Precision medicine has driven a major change in the treatment of many forms of cancer. The discovery that each patient is different and each tumor mass has its own characteristics has shifted the focus of basic and clinical research to the singular individual. Liquid biopsy (LB), in this sense, presents new scenarios in personalized medicine through the study of molecules, factors, and tumor biomarkers in blood such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), exosomes and circulating tumor microRNAs (ct-miRNAs). Moreover, its easy application and complete absence of contraindications for the patient make this method applicable in a great many fields. Melanoma, given its highly heterogeneous characteristics, is a cancer form that could significantly benefit from the information linked to liquid biopsy, especially in the treatment management. In this review, we will focus our attention on the latest applications of liquid biopsy in metastatic melanoma and possible developments in the clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UOC Oncological Translational Research, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
- SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
- Clinical Trial Center, IRCSS-Regina Elena National Cancer Institute/San Gallicano Dermatological Institute, 00144 Rome, Italy.
- Division of Medical Oncology 1, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
- Department of Clinical and Molecular Medicine, "La Sapienza", University of Rome, 00185 Rome, Italy.
- Scientific Direction, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
ORCID-Profile: Elena Ricciardi, Elena Giordani, Giovanna Ziccheddu, Italia Falcone, Maurizio Fanciulli, Fabio Valenti
Förderung
- Italian Ministry of Health
Zitieren
APA
Ricciardi, E., Giordani, E., Ziccheddu, G., Falcone, I., Giacomini, P., Fanciulli, M., Russillo, M., Cerro, M., Ciliberto, G., Morrone, A., Guerrisi, A., & Valenti, F. (2023). Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24044014
Vancouver
Ricciardi E, Giordani E, Ziccheddu G, Falcone I, Giacomini P, Fanciulli M, et al. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24044014
BibTeX
@article{Ricciardi2023,
author = {Ricciardi, Elena and Giordani, Elena and Ziccheddu, Giovanna and Falcone, Italia and Giacomini, Patrizio and Fanciulli, Maurizio and Russillo, Michelangelo and Cerro, Marianna and Ciliberto, Gennaro and Morrone, Aldo and Guerrisi, Antonino and Valenti, Fabio},
title = {Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24044014}
}
EUVIMED